Alendronate is a bisphosphonate medication used to treat and prevent osteoporosis in postmenopausal women and men, as well as for the management of Paget's disease of bone. By binding to bone hydroxyapatite,… Read more
Alendronate is a bisphosphonate medication used to treat and prevent osteoporosis in postmenopausal women and men, as well as for the management of Paget's disease of bone. By binding to bone hydroxyapatite, this agent effectively inhibits osteoclast-mediated bone resorption, thereby helping to maintain bone density and structural integrity. This category provides essential reference standards, including the active pharmaceutical ingredient, relevant impurities, metabolites, and stable isotope labelled compounds. These high-quality reference materials are indispensable for pharmaceutical laboratories conducting rigorous analytical testing, such as impurity profiling, assay development, and method validation. Using these precisely characterized standards ensures accurate quantitative and qualitative analysis, facilitating consistent quality control during the drug lifecycle and supporting adherence to regulatory standards in stability and release testing.